Live Breaking News & Updates on Psychedelics Genetic Test Kit

Stay updated with breaking news from Psychedelics genetic test kit. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Entheon Biomedical Corp. Launches HaluGen's Psychedelics Genetic Test


Entheon Biomedical Corp. Launches HaluGen s Psychedelics Genetic Test
HaluGen s DNA genetic testing provides insights into the sensitivity and risks associated with psychedelic-assisted psychotherapy
Vancouver, British Columbia (Newsfile Corp. - April 6, 2021) - Entheon Biomedical Corp. (CSE: ENBI) (FSE: 1XU1) ( Entheon or the Company ), a biotechnology company focused on developing psychedelic medicines to treat addiction, announces the launch of the industry s first Psychedelics Genetic Test Kit, developed by wholly-owned subsidiary, HaluGen Life Sciences Inc. ( HaluGen ), and that it is now available for sale within Canada.
HaluGen s psychedelic pre-screening platform and DNA testing provides genetic, personal and familial insights to better inform one s psychedelic assisted therapy experience. By obtaining DNA test results, individuals and healthcare professionals are equipped with data to improve psychedelic assisted therapy patient care and reduce side effects ....

United States , United Kingdom , British Columbia , Timothy Ko , Joseph Cullen , Halugen Life Sciences Inc , Technology Platform , Entheon Biomedical Corp , British Columbia Newsfile Corp , Assay Development , Testing Services Agreement , Lobo Genetics Inc , European Union , Canadian Securities Exchange , Psychedelics Genetic Test Kit , Halugen Life Sciences , Lobo Genetics , Product Supply , Psychedelic Pre Screening Genetic Test , Psychedelics Genetic Test , Polymerase Chain Reaction , Chief Executive Officer , John Lem , Crystal Quast , Forward Looking , Compensation Shares ,